Search Results Search Sort by RelevanceMost Recent Case and Commentary Feb 2021 How Should Clinicians Respond to Language Barriers That Exacerbate Health Inequity? Jason Espinoza, MD and Sabrina Derrington, MD, MA, HEC-C Limited language proficiency is a driver of health inequity and exacerbates other social determinants of health. AMA J Ethics. 2021;23(2):E109-116. doi: 10.1001/amajethics.2021.109. Case and Commentary Feb 2021 How Should Physicians and Pharmacists Collaborate to Motivate Health Equity in Underserved Communities? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES Physicians and pharmacists play key roles in addressing social determinants of health and health inequity. AMA J Ethics. 2021;23(2):E117-126. doi: 10.1001/amajethics.2021.117. Case and Commentary Jun 2021 How Should Clinicians Respond to Children in Transgenerationally Traumatized Families? Diego Chaves-Gnecco, MD, MPH Pediatricians have obligations to find causes of children’s stress and respond with care to their clinical and social vulnerabilities. AMA J Ethics. 2021;23(6):E465-470. doi: 10.1001/amajethics.2021.465. Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542. Policy Forum Aug 2019 Should a Law Governing the Pharmaceutical Market Be Ethically Examined Based on Its Intent or Its Practical Applications? Jordan M. Warchol, MD, MPH In 1984, Hatch-Waxman tried to balance drug innovation against availability; it was tested in the US Supreme Court in 2013. AMA J Ethics. 2019;21(8):E661-667. doi: 10.1001/amajethics.2019.661.
Case and Commentary Feb 2021 How Should Clinicians Respond to Language Barriers That Exacerbate Health Inequity? Jason Espinoza, MD and Sabrina Derrington, MD, MA, HEC-C Limited language proficiency is a driver of health inequity and exacerbates other social determinants of health. AMA J Ethics. 2021;23(2):E109-116. doi: 10.1001/amajethics.2021.109.
Case and Commentary Feb 2021 How Should Physicians and Pharmacists Collaborate to Motivate Health Equity in Underserved Communities? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES Physicians and pharmacists play key roles in addressing social determinants of health and health inequity. AMA J Ethics. 2021;23(2):E117-126. doi: 10.1001/amajethics.2021.117.
Case and Commentary Jun 2021 How Should Clinicians Respond to Children in Transgenerationally Traumatized Families? Diego Chaves-Gnecco, MD, MPH Pediatricians have obligations to find causes of children’s stress and respond with care to their clinical and social vulnerabilities. AMA J Ethics. 2021;23(6):E465-470. doi: 10.1001/amajethics.2021.465.
Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542.
Policy Forum Aug 2019 Should a Law Governing the Pharmaceutical Market Be Ethically Examined Based on Its Intent or Its Practical Applications? Jordan M. Warchol, MD, MPH In 1984, Hatch-Waxman tried to balance drug innovation against availability; it was tested in the US Supreme Court in 2013. AMA J Ethics. 2019;21(8):E661-667. doi: 10.1001/amajethics.2019.661.